Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7386768 | 6970828 | F | 7386768-3 | 20090228 | 20110324 | 20110331 | EXP | FR-ASTRAZENECA-2009CG00658 | AZPRODUW00 | 25579 | DY | M | Y | 100 | KG | 20110331 | MD | FRANCE |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
7386768 | 1016138907 | C | EFFEXOR | 1 | ORAL | ||||||
7386768 | 1016138908 | C | IMOVANE | 2 | ORAL | ||||||
7386768 | 1016138909 | C | DECAPEPTYL | 2 | SUBCUTANEOUS | ||||||
7386768 | 1016138905 | SS | VANDETANIB | 2 | ORAL | ||||||
7386768 | 1016138906 | C | PREVISCAN | 2 | ORAL | ||||||
7386768 | 1016138904 | PS | CASODEX | 1 | ORAL | 020498 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
7386768 | 1016138907 | DEPRESSION |
7386768 | 1016138908 | INSOMNIA |
7386768 | 1016138909 | PROSTATE CANCER |
7386768 | 1016138905 | PROSTATE CANCER METASTATIC |
7386768 | 1016138906 | THROMBOSIS PROPHYLAXIS |
7386768 | 1016138904 | PROSTATE CANCER METASTATIC |
Outcome of event
Event ID | OUTC COD |
---|---|
7386768 | HO |
Reactions reported
Event ID | PT |
---|---|
7386768 | PHOTOSENSITIVITY REACTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
7386768 | 1016138905 | 20090110 | 20090406 | 87 | DAY |
7386768 | 1016138904 | 20090110 | 20090406 | 87 | DAY |